OTC Dry Eye Drops

Global OTC Dry Eye Drops Market to Reach US$5.6 Billion by 2030

The global market for OTC Dry Eye Drops estimated at US$3.8 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Generics OTC Dry Eye Drops, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Branded OTC Dry Eye Drops segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 11.0% CAGR

The OTC Dry Eye Drops market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global OTC Dry Eye Drops Market – Key Trends & Drivers Summarized

Why Is the OTC Dry Eye Drops Market Expanding at an Unprecedented Pace?

The OTC dry eye drops market is experiencing substantial growth due to the increasing prevalence of dry eye syndrome, driven by lifestyle changes, prolonged screen time, and environmental factors. With the rise of digital device usage, more people suffer from eye strain, leading to chronic dryness and irritation. Additionally, aging populations and growing cases of conditions such as Sjögren’s syndrome and meibomian gland dysfunction are fueling demand for over-the-counter (OTC) eye drops.

Another key driver is the increasing consumer preference for self-medication and convenience. As awareness of dry eye symptoms grows, more individuals are opting for OTC solutions rather than seeking prescriptions. The availability of preservative-free, lubricating, and therapeutic formulations has made OTC dry eye drops the go-to solution for managing mild to moderate cases of dry eye syndrome.

How Are Innovations in Formulation Enhancing OTC Dry Eye Drops?

Advancements in ophthalmic formulation science are transforming the OTC dry eye drops market, offering more effective and long-lasting solutions. The introduction of lipid-based and nano-emulsion eye drops is improving moisture retention and providing better relief for patients with evaporative dry eye. Additionally, electrolyte-enriched and hyaluronic acid-based formulations are becoming popular for their enhanced hydration properties and ability to mimic natural tears.

Another significant development is the rise of preservative-free eye drops, which reduce irritation and allergic reactions. Multi-dose preservative-free packaging technology is also gaining traction, ensuring sterility while eliminating harmful chemical preservatives. The incorporation of herbal and natural ingredients, such as chamomile and aloe vera, is further catering to the demand for clean-label and holistic eye care solutions.

Are Digital Health Trends and E-Commerce Reshaping the Market?

The increasing adoption of digital health and e-commerce is reshaping how OTC dry eye drops reach consumers. Online pharmacies and direct-to-consumer (DTC) brands are expanding access to a wide variety of products, making it easier for consumers to compare ingredients and read customer reviews before purchasing. Subscription-based eye care solutions are also gaining popularity, ensuring regular replenishment and convenience for frequent users.

Additionally, AI-powered diagnostics and virtual eye assessments are enabling personalized product recommendations. Digital eye strain detection apps and telemedicine consultations are further guiding consumers in selecting the most suitable OTC dry eye drops based on their symptoms and lifestyle habits. As digital health integration continues, market growth is expected to accelerate.

What’s Driving the Growth of the OTC Dry Eye Drops Market?

The growth in the OTC dry eye drops market is driven by several factors, including the increasing prevalence of dry eye syndrome, growing consumer reliance on self-care solutions, and continuous advancements in ophthalmic formulations. The rise of e-commerce and digital health technologies is further expanding market accessibility.

Additionally, regulatory approvals for innovative eye drop formulations, increasing awareness of eye health, and the development of specialized dry eye products for different consumer segments—such as contact lens users and allergy sufferers—are fueling market expansion. As lifestyle factors continue to contribute to dry eye syndrome, demand for OTC dry eye drops is expected to rise significantly.

SCOPE OF STUDY:

The report analyzes the OTC Dry Eye Drops market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Generics OTC Dry Eye Drops, Branded OTC Dry Eye Drops); Product (Preservative OTC Dry Eye Drops, Preservatives Free OTC Dry Eye Drops); Viscosity (Low Viscosity, High Viscosity); Distribution Channel (Retail Pharmacies, Drugstores & Supermarkets, Online Pharmacies, Other Distribution Channels)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Akorn, Inc.
• Alcon Inc.
• Allergan (AbbVie Inc.)
• Bausch + Lomb Incorporated
• Bruder Healthcare Company
• Entod International
• Eyevance Pharmaceuticals LLC
• Hilco Vision
• Jamjoom Pharmaceuticals Co.
• Johnson & Johnson Vision Care, Inc.
• NovaBay Pharmaceuticals, Inc.
• Novartis AG
• OASIS Medical, Inc.
• Prestige Consumer Healthcare Inc.
• Rohto Pharmaceutical Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Scope Ophthalmics Ltd.
• Similasan Corporation
• TheraTears (Akorn Consumer Health)
• URSA Pharmaceuticals, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.